Shin Nippon Biomedical Laboratories, Ltd.(JP:2395)
¥1,229.00+28.00 (+2.33%)
JP:2395
Shin Nippon Biomedical Laboratories, Ltd. financials statements
¥1,229.00
At close:+28.00 (+2.33%)
Want to see JP:2395 full AI Analyst Report?
Shin Nippon Biomedical Laboratories, Ltd. (2395) Income Statement
2 Followers
Shin Nippon Biomedical Laboratories, Ltd. Income Statement
Last quarter (Q1 2026), Shin Nippon Biomedical Laboratories, Ltd.'s total revenue was ¥7.87B, an increase of 21.48% from the same quarter last year. In Q1, Shin Nippon Biomedical Laboratories, Ltd.'s net income was ¥1.06B. See Shin Nippon Biomedical Laboratories, Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ¥ 32.52B | ¥ 32.41B | ¥ 26.45B | ¥ 25.09B | ¥ 17.75B | |
| ¥ 15.83B | ¥ 16.57B | ¥ 14.28B | ¥ 13.05B | ¥ 9.69B | |
| ¥ 13.17B | ¥ 13.59B | ¥ 10.12B | ¥ 7.80B | ¥ 5.49B | |
| Depreciation and Amortization | ¥ 3.43B | ¥ 2.61B | ¥ 1.87B | ¥ 1.60B | ¥ 1.18B |
| ¥ 6.09B | ¥ 8.83B | ¥ 8.98B | ¥ 9.49B | ¥ 9.49B | |
| ¥ 2.65B | ¥ 2.99B | ¥ 4.16B | ¥ 5.25B | ¥ 4.20B | |
| ¥ 3.59B | ¥ 3.03B | ¥ 2.81B | ¥ 2.51B | ¥ 3.99B | |
| ¥ 6.25B | ¥ 6.01B | ¥ 6.97B | ¥ 7.76B | ¥ 8.18B | |
| ¥ 4.57B | ¥ 4.92B | ¥ 5.53B | ¥ 6.06B | ¥ 7.13B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 109.69 | ¥ 118.30 | ¥ 132.86 | ¥ 145.57 | ¥ 171.21 |
| Diluted EPS | ¥ 109.69 | ¥ 118.30 | ¥ 132.86 | ¥ 145.57 | ¥ 171.21 |
| Weighted Average Shares Outstanding | 41.63M | 41.63M | 41.63M | 41.63M | 41.63M |
| Weighted Average Shares Outstanding (Diluted) | 41.63M | 41.63M | 41.63M | 41.63M | 41.63M |
Currency in JPY
